Nu-Med Plus, Inc. (NUMD)
| Market Cap | 1.22M -53.2% |
| Revenue (ttm) | n/a |
| Net Income | -20.79K |
| EPS | -0.00 |
| Shares Out | 83.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,424 |
| Open | 0.0146 |
| Previous Close | 0.0146 |
| Day's Range | 0.0146 - 0.0146 |
| 52-Week Range | 0.0095 - 0.0370 |
| Beta | -2.13 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 9, 2026 |
About Nu-Med Plus
Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable ... [Read more]
Financial Performance
Financial StatementsNews
NU-Med Plus Announces Acquisition of Avid Gold and Agreement to Acquire Canadian Gold Properties
Transaction expected to expand Nu-Med's operations into gold exploration and development in Canada Salt Late City, Utah and London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - Ju...